NCT05043701View on ClinicalTrials.gov

Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

February 28, 2026

Conditions
Recurrent Glioblastoma
Interventions
DRUG

Personalized drug combination

A personalized drug combination will be prescribed to each patient based on the functional drug screen

Trial Locations (1)

Unknown

RECRUITING

Oslo University Hospital, Oslo

Sponsors
All Listed Sponsors
collaborator

Institute for Molecular Medicine

OTHER

lead

Oslo University Hospital

OTHER